Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy

Journal of Translational Medicine

Volumn 2, Issue , 2004, Pages

  Grasso, Marco ^a   Lania, Caterina ^b   Blanco, Salvatore ^a   Baruffi, Marco ^a   Mocellin, Simone ^c  

^a DESIO HOSPITAL   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Neoadjuvant therapy; Prostatic cancer; PSA; qrt PCR

Indexed keywords

BUSERELIN; MESSENGER RNA; NILUTAMIDE; PROSTATE SPECIFIC ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; CARCINOMA CELL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MALE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; TISSUE SECTION;

EID: 4344638007     PISSN: 14795876     EISSN: None     Source Type: Journal    
DOI: 10.1186/1479-5876-2-13     Document Type: Article

References (19)

1. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics. CA Cancer J Clin 2000, 50:7-33.
2. Gerald WH, Farhang R, Farhat A: Cancer control with radical prostatectomy alone in 1000 consecutive patients. J of Urol 2002, 167:528-534.
3. Martin E, Gleave , S Larry Goldenberg, Joseph L Chin: Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects. J of Urol 2001, 166:500-507.
4. Grasso M, Buonaguidi A, Mondina R: Plasma sex hormone binding globulin in patients with prostatic carcinoma. Cancer 1990, 66(2):354-7.
5. Theodorescu D, Frierson Jr HF, Sikes RA: Molecular determination of surgical margins using fossa biopsies at radical prostatectomy. J of Urol 1999, 161:1442-1448.
6. Straub B, Muller M, Krause H: Reverse trascriptase-polymerase chain reaction for prostate-specific antigen inthe molecular staging of pelvic surgical margins after radical prostatectomy. Urology 2001, 57(5):1006-1011.
7. Van Poppel H: Neoadjuvant hormone therapy and radical prostatectomy: the jury is still out. Eur Urol Review 2001, 39(Suppl 1):10-4.
8. Panelli MC, Wang E, Monsurro V, Marincola FM: The role of quantitative PCR for the immune monitoring of cancer patients. Expert Opin Biol Ther 2002, 2(5):537-44.
9. Kammula US, Marincola FM, Rosenberg SA: Real-time quantitative polymerase chain reaction assessment of immnune reactivity in melanoma patients after tumor peptide vaccination. J Natl Cancer Inst 2000, 92(16):1336-44.
10. Walsh PC, Jewett HJ: Radical surgery for prostatic Cancer. Cancer 1980, 45(7 Suppl):1906-1911.
11. Iversen P, Adolfsson J, Johansson JE: Localized prostate cancer: A Scandinavian view. Monogr Urol 1994, 15:93-112.
12. Montironi R, Diamanti L, Santinelli A, Galetti-Prayer T: Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer. Initial results of the Italian PROSIT study. Pathol Res Pract 1999, 195:201-208.
13. Macfarlan MT, Abi-Add A, Stein A: Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer. J of Urol 1993, 150:132-134.
14. Oesterling JE, Andrews PE, Suman VJ, Zincke H, Myers RP: Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor. J Urol 1993, 149:779-782.
15. Paulson DF: Neoadjuvant androgen deprivation therapy prior to radical prostatectomy. Urology 1996, 48:539.
16. Aus G, Abrahamsson PA, Ahlgren G: Hormonal treatment before radical prostatectomy: a 3-years follow-up. J of Urol 1998, 159:2013-2016.
17. Van Poppel H, De Ridder D, Elgamal AA, Van de Voorde W, Werbrouck P, Ackaert K, Oyen R, Pittomills G, Baert L: Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group. J of Urol 1995, 154(2 Pt 1):429-434.
18. Nitsche S, Steuer N, Schmidt CA: Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol 2000, 38:2734-2737.
19. Yoshika S, Fujiwara Y, Sugita Y: Real-time rapid reverse transcriptase-polymerase chain reaction for intraoperative diagnosis of lymph node micrometastasis: clinical application for cervical lymph node dissection in esophageal cancers. Surgery 2002, 132(1):34-40.